Herantis Pharma Financials
| HRTIS Stock | EUR 1.44 0.02 1.41% |
Herantis |
Understanding current and past Herantis Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Herantis Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Herantis Pharma's assets may result in an increase in income on the income statement.
Herantis Pharma Stock Summary
Herantis Pharma competes with Nanoform Finland, Nexstim Oyj, Tokmanni Group, and Kamux Suomi. Herantis Pharma Oyj, a drug development company, focuses on developing regenerative therapeutics. The company was founded in 2008 and is based in Espoo, Finland. Herantis Pharma operates under Pharmaceuticals And Biosciences classification in Finland and is traded on Helsinki Exchange. It employs 13 people.| Instrument | Finland Stock View All |
| Exchange | Helsinki Exchange |
| ISIN | FI4000087861 |
| Business Address | Bertel Jungin Aukio |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.herantis.com |
| Phone | 358 9222 1195 |
| Currency | EUR - Euro |
You should never invest in Herantis Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Herantis Stock, because this is throwing your money away. Analyzing the key information contained in Herantis Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Herantis Pharma Key Financial Ratios
Herantis Pharma's financial ratios allow both analysts and investors to convert raw data from Herantis Pharma's financial statements into concise, actionable information that can be used to evaluate the performance of Herantis Pharma over time and compare it to other companies across industries.Herantis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Herantis Pharma's current stock value. Our valuation model uses many indicators to compare Herantis Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Herantis Pharma competition to find correlations between indicators driving Herantis Pharma's intrinsic value. More Info.Herantis Pharma Oyj is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Herantis Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Herantis Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Herantis Pharma Oyj Systematic Risk
Herantis Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Herantis Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Herantis Pharma Oyj correlated with the market. If Beta is less than 0 Herantis Pharma generally moves in the opposite direction as compared to the market. If Herantis Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Herantis Pharma Oyj is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Herantis Pharma is generally in the same direction as the market. If Beta > 1 Herantis Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Herantis Pharma March 15, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Herantis Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Herantis Pharma Oyj. We use our internally-developed statistical techniques to arrive at the intrinsic value of Herantis Pharma Oyj based on widely used predictive technical indicators. In general, we focus on analyzing Herantis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Herantis Pharma's daily price indicators and compare them against related drivers.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 10.86 | |||
| Value At Risk | (3.62) | |||
| Potential Upside | 6.62 |
Complementary Tools for Herantis Stock analysis
When running Herantis Pharma's price analysis, check to measure Herantis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Herantis Pharma is operating at the current time. Most of Herantis Pharma's value examination focuses on studying past and present price action to predict the probability of Herantis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Herantis Pharma's price. Additionally, you may evaluate how the addition of Herantis Pharma to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |